Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine

被引:41
作者
Aibana, Omowunmi [1 ]
Bachmaha, Mariya [2 ]
Krasiuk, Viatcheslav [3 ]
Rybak, Natasha [4 ]
Flanigan, Timothy P. [4 ]
Petrenko, Vasyl [3 ]
Murray, Megan B. [5 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Div Gen Internal Med, Houston, TX 77030 USA
[2] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA
[3] Bogomolets Natl Med Univ, Dept Pulmonol, Kiev, Ukraine
[4] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI USA
[5] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA
关键词
Multidrug-resistant; Tuberculosis; Risk factors; Treatment outcomes; AGGRESSIVE REGIMENS; TREATMENT FAILURE; DEFAULT; PREDICTORS; MORTALITY; TOMSK;
D O I
10.1186/s12879-017-2230-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Ukraine is among ten countries with the highest burden of multidrug-resistant TB (MDR-TB) worldwide. Treatment success rates for MDR-TB in Ukraine remain below global success rates as reported by the World Health Organization. Few studies have evaluated predictors of poor MDR-TB outcomes in Ukraine. Methods: We conducted a retrospective analysis of patients initiated on MDR-TB treatment in the Kyiv Oblast of Ukraine between January 01, 2012 and March 31st,2015. We defined good treatment outcomes as cure or completion and categorized poor outcomes among those who died, failed treatment or defaulted. We used logistic regression analyses to identify baseline patient characteristics associated with poor MDR-TB treatment outcomes. Results: Among 360 patients, 65 (18.1%) achieved treatment cure or completion while 131 (36.4%) died, 115 (31.9%) defaulted, and 37 (10.3%) failed treatment. In the multivariate analysis, the strongest baseline predictors of poor outcomes were HIV infection without anti-retroviral therapy (ART) initiation (aOR 10.07; 95% CI 1.20-84.45; p 0.03) and presence of extensively-drug resistant TB (aOR 9.19; 95% CI 1.17-72.06; p 0.03). HIV-positive patients initiated on ART were not at increased risk of poor outcomes (aOR 1.43; 95% CI 0.58-3.54; p 0.44). There was no statistically significant difference in risk of poor outcomes among patients who received baseline molecular testing with Gene Xpert compared to those who were not tested (aOR 1.31; 95% CI 0.63-2.73). Conclusions: Rigorous compliance with national guidelines recommending prompt initiation of ART among HIV/TB co-infected patients and use of drug susceptibility testing results to construct treatment regimens can have a major impact on improving MDR-TB treatment outcomes in Ukraine.
引用
收藏
页数:7
相关论文
共 29 条
[1]  
[Anonymous], GLOB TUB REP 2016
[2]  
[Anonymous], 2014, UN CLIN PROT PRIM SE
[3]  
Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413
[4]   Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? [J].
Ciobanu, A. ;
Domente, L. ;
Soltan, V. ;
Bivol, S. ;
Severin, L. ;
Plesca, V. ;
Van den Bergh, R. ;
Kumar, A. M. V. ;
de Colombani, P. .
PUBLIC HEALTH ACTION, 2014, 4 :S59-S63
[5]   Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success [J].
Daniels, Johnny Flippie ;
Khogali, Mohammed ;
Mohr, Erika ;
Cox, Vivian ;
Moyo, Sizulu ;
Edginton, Mary ;
Hinderaker, Sven Gudmund ;
Meintjes, Graeme ;
Hughes, Jennifer ;
De Azevedo, Virginia ;
van Cutsem, Gilles ;
Cox, Helen Suzanne .
PLOS ONE, 2015, 10 (11)
[6]   Pattern of primary tuberculosis drug resistance and associated treatment outcomes in Transnistria, Moldova [J].
Dolgusev, O. ;
Obevzenco, N. ;
Padalco, O. ;
Pankrushev, S. ;
Ramsay, A. ;
Van den Bergh, R. ;
Manzi, M. ;
Denisiuk, O. ;
Zachariah, R. .
PUBLIC HEALTH ACTION, 2014, 4 :S64-S66
[7]   Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence [J].
Farley, Jason E. ;
Ram, Malathi ;
Pan, William ;
Waldman, Stacie ;
Cassell, Gail H. ;
Chaisson, Richard E. ;
Weyer, Karin ;
Lancaster, Joey ;
Van der Walt, Martie .
PLOS ONE, 2011, 6 (07)
[8]   Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment [J].
Franke, Molly F. ;
Appleton, Sasha C. ;
Bayona, Jaime ;
Arteaga, Fernando ;
Palacios, Eda ;
Llaro, Karim ;
Shin, Sonya S. ;
Becerra, Mercedes C. ;
Murray, Megan B. ;
Mitnick, Carole D. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1844-1851
[9]   Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence [J].
Franke, Molly F. ;
Appleton, Sasha C. ;
Mitnick, Carole D. ;
Furin, Jennifer J. ;
Bayona, Jaime ;
Chalco, Katiuska ;
Shin, Sonya ;
Murray, Megan ;
Becerra, Mercedes C. .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (06) :770-776
[10]   Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting [J].
Gandhi, N. R. ;
Andrews, J. R. ;
Brust, J. C. M. ;
Montreuil, R. ;
Weissman, D. ;
Heo, M. ;
Moll, A. P. ;
Friedland, G. H. ;
Shah, N. S. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (01) :90-97